Japan approves Gilead Sciences' remdesivir as COVID-19 drug
Published
Japan has approved Gilead Sciences Inc's remdesivir as a treatment for COVID-19, the health ministry said on Thursday, making it the country's first officially authorised drug for the disease.
Full Article